75 related articles for article (PubMed ID: 22118291)
1. 'Let the computer choose?': the experience of participants in a randomised preference trial of medical versus surgical termination of pregnancy.
Lie M; May C; Kelly T; Robson S
Sociol Health Illn; 2012 Jun; 34(5):746-60. PubMed ID: 22118291
[TBL] [Abstract][Full Text] [Related]
2. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
[TBL] [Abstract][Full Text] [Related]
3. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
5. The efficacy, safety and acceptability of medical termination of pregnancy provided by standard care by doctors or by nurse-midwives: a randomised controlled equivalence trial.
Kopp Kallner H; Gomperts R; Salomonsson E; Johansson M; Marions L; Gemzell-Danielsson K
BJOG; 2015 Mar; 122(4):510-7. PubMed ID: 25040643
[TBL] [Abstract][Full Text] [Related]
6. Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
Kelly T; Suddes J; Howel D; Hewison J; Robson S
BJOG; 2010 Nov; 117(12):1512-20. PubMed ID: 20860598
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
8. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
[TBL] [Abstract][Full Text] [Related]
9. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial.
World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation
Acta Obstet Gynecol Scand; 2001 May; 80(5):447-51. PubMed ID: 11328223
[TBL] [Abstract][Full Text] [Related]
10. Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study.
Rørbye C; Nørgaard M; Nilas L
Contraception; 2004 Nov; 70(5):393-9. PubMed ID: 15504379
[TBL] [Abstract][Full Text] [Related]
11. Lowering the doses of mifepristone and gameprost for early abortion: a randomised controlled trial. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation.
BJOG; 2001 Jul; 108(7):738-42. PubMed ID: 11467701
[TBL] [Abstract][Full Text] [Related]
12. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
13. Choosing early pregnancy termination methods in Urban Mozambique.
Mitchell EM; Kwizera A; Usta M; Gebreselassie H
Soc Sci Med; 2010 Jul; 71(1):62-70. PubMed ID: 20452107
[TBL] [Abstract][Full Text] [Related]
14. Deciding to join a perinatal randomised controlled trial: experiences and views of pregnant women enroled in the Magpie Trial.
Smyth RM; Jacoby A; Elbourne D
Midwifery; 2012 Aug; 28(4):E478-85. PubMed ID: 21944570
[TBL] [Abstract][Full Text] [Related]
15. [Early medical abortion. An update].
Lidegaard O; Larsen JF
Ugeskr Laeger; 1999 May; 161(22):3275-7. PubMed ID: 10485205
[TBL] [Abstract][Full Text] [Related]
16. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.
Gemzell-Danielsson K; Ostlund E
Acta Obstet Gynecol Scand; 2000 Aug; 79(8):702-6. PubMed ID: 10949238
[TBL] [Abstract][Full Text] [Related]
17. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study.
Hajri S; Blum J; Gueddana N; Saadi H; Maazoun L; Chélli H; Dabash R; Winikoff B
Contraception; 2004 Dec; 70(6):487-91. PubMed ID: 15541411
[TBL] [Abstract][Full Text] [Related]
18. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
[TBL] [Abstract][Full Text] [Related]
19. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
20. Early pregnancy termination with mifepristone and misoprostol in Norway.
Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
